Apical Periodontitis Clinical Trial
Official title:
Transplantation of Allogeneic Mesenchymal Stromal Cells in Patients With Immature Apex Teeth With Pulp Necrosis and Chronic Apical Periodontitis
The purpose of the study is to evaluate the effect of Mesenchymal Stromal Cell (MSC)
implantation on pulp and periapical regeneration of immature teeth with pulp necrosis and
chronic apical periodontitis.
BACKGROUND:
- Post-traumatic pulp necrosis prevents root development in children and adolescents.
- The multipotent ability of MSC to differentiate into bone-forming cells (osteoblasts)
and dentin-forming cells (Odontoblast) has allowed the development of protocols to
induce dental pulp regeneration in preclinical models and patients with immature teeth
with pulpal necrosis.
IMPACT:
- Worldwide, post-traumatic pulp necrosis in children and adolescents constitutes a health
problem in the endodontic area.
- Treatment with MSC would provide an effective therapeutic alternative to patients with
pulp necrosis and incomplete root formation.
- The possible pulp and periapical regeneration of immature teeth induced by MSC would
have a huge impact on the treatment of these patients.
Eligibility for EMC implant study Age: 6 to 16 years Sex: Male or Female Healthy volunteers
accepted: NO.
TREATMENT GROUPS:
In the present study, the implantation of MSC will be performed in patients with immature
teeth with pulpal necrosis with apical periodontitis, who will receive the appropriate
endodontic treatment (according to the guidelines of the American Association of Endodontics)
and implantation of allogeneic BM-MSC . This group will be compared with the history made in
the Postgraduate Endodontics of the Universidad Central de Venezuela (UCV) and with
international case series made by revascularization.
Clinical follow-up of each patient:
1. Clinical controls (facial evaluation, gingival evaluation, apical palpation, horizontal
and vertical percussion, cold and heat sensitivity tests) will be carried out on days 0,
7, 30, 90, 180 and 364. Additionally, a clinical evaluation will be carried out at the
two years post-implantation of MSC.
2. Radiological controls will be carried out on days 0, 7, 30, 90, 180 and 364.
Additionally, they will be carried out two years post-implantation of MSC.
3. A tomographic evaluation will be performed when was evident periapical repair in a
periapical radiograph. To measure root formation, root canal narrowing and verification
the periapical repair in 3D.
The endodontic procedure in the patients included in this study will focus on cases of pulp
necrosis with apical periodontitis without evidence of infectious processes.
MATERIALS AND METHODS. Reagents Murine monoclonal antibodies, directed against human
differentiation antigens (CD34, CD45, CD14, CD90, CD73, CD29, CD49b, CD166), conjugated to
fluorescein isothiocyanate (CFI) or phycoerythrin (PE) were purchased from BD Biosciences
(USA).
Isolation and culture of mesenchymal stromal cells (MSC) obtained from human bone marrow. In
the present study, isolated EMFs from bone marrow (BM) from patients with a diagnosis of
post-traumatic nonunion (failure of a bone union at fracture sites) will be used. These cells
were transplanted into the pseudoarthrosis site to induce bone regeneration in these
patients. The protocol for bone regeneration through EMF transplantation was carried out at
the University Hospital of Caracas, Hospital Universitario de Los Andes, Hospital Pérez de
León II and has the approval of the Bioethics Committees of each institution and each patient
through informed consent. In this protocol, the BM of each patient was isolated by a puncture
in the iliac crest. This procedure was performed in the operating room, under anesthesia and
by a medical specialist. The MO aspirate was placed in alpha-MEM medium (Invitrogen, USA)
with heparin (Sanofi Aventis). The mononuclear cells were separated by centrifugation on a
Ficoll-Hypaque gradient (GE Healthcare, Sweden) and cultured in alpha-MEM-Chang medium
(Irvine Scientific, USA) enriched with 20% autologous serum. These cells were kept in culture
in a controlled environment at 37ºC and 5% CO2. After 72 hours, non-adherent cells were
eliminated, and a basal culture medium (alpha-MEM-Chang / 20% autologous serum) was added.
Their adherence to the plastic isolated the MSCs. Culture medium exchanges were made until
reaching a confluence close to 70-80%. The MSCs were expanded by pealing the cultures,
following the process described above. Microbiological examinations were performed after
obtaining the BM and before performing the MSC implantation. After using MSC, a batch of
these cells were cryopreserved at -70 -C.
Phenotypic characterization of MSC. Phenotypic characterization studies of MSC were carried
out by flow cytometry. For which the MO adherent cells were detached from the culture flask
by using trypsin-like enzymes. Subsequently, the cells were incubated with antibodies
specific for MSC markers (CD90, CD73, CD105, CD29, CD166 and CD49b) and hematopoietic (CD34,
CD45 and CD14). Cytometric analysis of the expression markers showed that 100% of the cells
used for transplantation in each patient were MSC.
MSC differentiation studies. The multipotential differentiation capacity of MSCs was examined
by culturing these cells in osteogenic, chondrogenic and adipogenic differentiation media,
following a methodology similar to that previously described. Briefly, the MSCs were detached
and seeded in 24-well culture plates at a cell density of 5x104 per well, proceeding to add
the corresponding differentiation medium. For osteogenic differentiation, MSCs were cultured
in the presence of basal medium enriched with dexamethasone (100nM, Biotech), ascorbic acid
(10mM, Sigma), inorganic phosphate (1.8mM, Merck) and beta-glycerol phosphate (2mM, Sigma).
For chondrogenic differentiation, cells were cultured in a commercial medium for chondrocytes
(Cell Application, USA) and for differentiation towards the adipogenic lineage the commercial
medium NH Adipodiff Human (Miltenyi, USA) was used. In all cases, the cells were kept in
culture for 21-28 days with medium changes every 4-5 days. To demonstrate the changes
associated with the differentiation process, the cells were fixed using paraformaldehyde
(Merck, USA) and specific stains were performed for each case. Briefly, alizarin red to
detect calcium deposition (evidence of osteogenesis), Alcian blue to detect proteoglycans
(evidence of chondrogenesis), and oil red (Oil Red) to see lipids (evidence of adipogenesis).
In all cases, microscopic observation and photographic registration were carried out. For
endothelial differentiation (CEn), EMFs were cultured in MCDB 131 medium (Invitrogen, USA)
enriched with 10% autologous serum, 10µg / ml of human epidermal growth factor (hu-EGF, R&D)
and hydrocortisone (1µg / ml, Sigma).
MSC implantation in patients with pulp necrosis and apical periodontitis. All MSC processing
procedures will be carried out in the cleanroom of the IVIC Cell Therapy Unit following the
standards of good manufacturing practice (GMP). Allogeneic BM-MSC from patients diagnosed
with post-traumatic nonunion and treated with implantation of these cells will be used to
induce bone regeneration. The MSC to be used in this protocol have previously been
phenotypically and functionally characterized. The MSC will be thawed, grown and expanded as
previously described. A part of the cells will be kept in a medium for MSCs, and another part
will be cultured in endothelial differentiation medium (CEM-Endo). Once the required number
of MSCs and MSCs-Endo have been reached, a suspension of these cells (75,000 cells from each
of them) will be placed in sterile culture tubes containing DMEM-F12 culture medium, without
phenol red, supplemented with 20% autologous serum. Each tube containing MSC / MSC-Endo will
be transported in a small biological sample transport cellar, at room temperature, to the
Dentistry Service of the Instituto Venezolano de Investigaciones Científicas (IVIC).
Under sterile conditions, the patient will be locally anesthetized in the affected tooth
area; the root canal of the affected tooth will be exposed and prepared to perform the MSC /
MSC-Endo / PRP implant. At the same time, the culture medium supernatant is removed from each
tube and the CEM / CEM-Endo "button (pellet)" is resuspended in autologous platelet-rich
plasma (PRP). Subsequently to the MSC / Endo / PRP suspension, 5% CaCl2 and thrombin will be
added. Immediately, and before the clot forms, 20 microliters of the CEM / CEM-Endo / PRP
suspension will be placed in the root canal, covered with a collagen membrane. Subsequently,
the obturation procedure with bioceramics will be carried out at the level of the pulp
chamber, ionomeric glass to protect the bioceramic and later composite resin to restore the
tooth.
Post-implantation clinical evaluation of EMF
1. Clinical controls (facial evaluation, gingival evaluation, apical palpation, horizontal
and vertical percussion, cold and heat sensitivity tests) will be carried out on days 0,
7, 30, 90, 180 and 364. Additionally, a clinical evaluation will be carried out at the
two years post-implantation of EMC.
2. Radiological controls will be carried out on days 0, 7, 30, 90, 180 and 364.
Additionally, they will be carried out two years post-implantation of mesenchymal
stromal cells.
3. A tomographic evaluation will be performed when the periapical repair will be evident in
a periapical radiograph.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04552132 -
Postoperative Pain and Healing in Teeth Treated With GentleWave or EndoActivator
|
N/A | |
Completed |
NCT04514991 -
Bone Regenerative Techniques in Endodontic Microsurgery
|
N/A | |
Withdrawn |
NCT04104789 -
Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - General
|
Phase 2 | |
Completed |
NCT01904552 -
Accuracy of ERCLMDs in Teeth With Apical Periodontitis
|
Phase 1 | |
Completed |
NCT05792787 -
Association Between Apical Periodontitis and Atherosclerotic Cardiovascular Diseases
|
||
Completed |
NCT06072742 -
Effect of Lifestyle on Caries and Apical Periodontitis
|
||
Completed |
NCT06226740 -
Effectiveness of Different Obturation Techniques
|
N/A | |
Completed |
NCT04126928 -
Validation of PUFA Index in Assessing Untreated Dental Caries Among Malaysian Adult Subpopulation
|
N/A | |
Recruiting |
NCT05439330 -
Application of a Dental-dedicated MRI in the Diagnosis of Temporomandibular Joint Disorders, Tissue Alterations Related to Third Molars, Periapical and Periodontal Inflammatory Diseases, and Implant Treatment Planning
|
N/A | |
Recruiting |
NCT06005545 -
A Study to Compare Various Root Canal Cleaning Devices Based on Cavitation,Ultrasonic and Conventional Methods.
|
N/A | |
Completed |
NCT02681276 -
Clinical and Microbiological Evaluation of 0.5% Versus 3% Sodium Hypochlorite in Root Canal Treatment
|
N/A | |
Completed |
NCT04072926 -
Effects of PDT and Bioceramic Filling on Periapical Healing and Postoperative Pain After Endodontic Retreatment
|
Early Phase 1 | |
Completed |
NCT03711942 -
Comparison of Healing of Apical Periodontitis in Periodontally Diseased and Healthy Patients.
|
N/A | |
Completed |
NCT03171376 -
Effect of Coronal Extent of Obturation on Endo-perio Lesions
|
N/A | |
Completed |
NCT03409887 -
Effect of Intraorifice Barrier on Healing of Apical Periodontitis
|
N/A | |
Recruiting |
NCT06043453 -
Revitalization of Traumatized Immature Permanent Teeth
|
||
Completed |
NCT03987659 -
Therapeutic Irrigation Procedures to Treat Apical Periodontitis
|
N/A | |
Completed |
NCT03288467 -
Effect of Sodium Hypochlorite Concentration on Success of Non-surgical Root Canal Treatment
|
N/A | |
Recruiting |
NCT03527602 -
FE in Anterior Teeth
|
N/A | |
Recruiting |
NCT03243357 -
In Vivo Assessment of Endodontics Procedures
|
N/A |